Hester Biosciences2329.90
+0.00 (-0.94%)

Hester Biosciences Share Price

2329.90+0.00 (-0.94%)
+39.36% past 1 Year

Corporate filings & documents

Announcements

20261105 Transcript of Earnings Conference Call for Q2 & H1 FY27 Financial Results
2 weeks ago
20261105 Transcript of Earnings Conference Call for Q2 & H1 FY27 Financial Results
2 weeks ago
20261106 Newpaper Clippings of Financial Results
2 weeks ago
20261106 Newpaper Clippings of Financial Results
2 weeks ago
Audio recording of the Earnings Conference Call for Q2 FY 27
2 weeks ago
Audio recording of the Earnings Conference Call for Q2 FY 27
2 weeks ago
Disclosure under regulation 30 of Listing Regulations - Board of Directors approved an unsecured loan to Hester Biosciences Africa Limited Foreign wholly-owned subsidiary of the Company.
2 weeks ago
Disclosure under regulation 30 of Listing Regulations - Board of Directors approved an unsecured loan to Hester Biosciences Africa Limited Foreign wholly-owned subsidiary of the Company.
2 weeks ago
20261105 Q2 & H1 FY27 Press Release
2 weeks ago
20261105 Q2 & H1 FY27 Press Release
2 weeks ago
Outcome of Board Meeting held on 5 November 2026 and Financial Results for the Q2 & H1 FY 2026-27
2 weeks ago
Outcome of Board Meeting held on 5 November 2026 and Financial Results for the Q2 & H1 FY 2026-27
2 weeks ago
This is to inform you that as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that the Company has scheduled investor interaction through a teleconference call on Thursday 5 November 2026 at 2:00 p.m. (IST) post the announcement of financial results for the quarter and six months period ended 30 September 2026. Details for joining the call are attached herewith.
3 weeks ago
This is to inform you that as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that the Company has scheduled investor interaction through a teleconference call on Thursday 5 November 2026 at 2:00 p.m. (IST) post the announcement of financial results for the quarter and six months period ended 30 September 2026. Details for joining the call are attached herewith.
3 weeks ago
This is to inform you that as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that the Company has scheduled investor interaction through a teleconference call on Thursday 5 November 2026 at 2:00 p.m. (IST) post the announcement of financial results for the quarter and six months period ended 30 September 2026. Details for joining the call are attached herewith.
3 weeks ago
This is to inform you that as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that the Company has scheduled investor interaction through a teleconference call on Thursday 5 November 2026 at 2:00 p.m. (IST) post the announcement of financial results for the quarter and six months period ended 30 September 2026. Details for joining the call are attached herewith.
3 weeks ago
Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2026
3 weeks ago
Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2026
3 weeks ago
Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2026
3 weeks ago
Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2026
3 weeks ago
Disclosure under Regulation 30 of the SEBI Listing Regulations - Completion of tenure of Independent Director Mr. Ameetkumar Desai with effect from closure of business hours on 27 October 2026 and consequently he ceased to be Independent Director of the Company.
3 weeks ago
Disclosure under Regulation 30 of the SEBI Listing Regulations - Completion of tenure of Independent Director Mr. Ameetkumar Desai with effect from closure of business hours on 27 October 2026 and consequently he ceased to be Independent Director of the Company.
3 weeks ago
Disclosure under Regulation 30 of the SEBI Listing Regulations - Completion of tenure of Independent Director Mr. Ameetkumar Desai with effect from closure of business hours on 27 October 2026 and consequently he ceased to be Independent Director of the Company.
3 weeks ago
Disclosure under Regulation 30 of the SEBI Listing Regulations - Completion of tenure of Independent Director Mr. Ameetkumar Desai with effect from closure of business hours on 27 October 2026 and consequently he ceased to be Independent Director of the Company.
3 weeks ago
Confirmation Certificate for the quarter ended 30 September 2026
1 month ago
Confirmation Certificate for the quarter ended 30 September 2026
1 month ago
Disclosure under Regulation 30 of the SEBI Listing Regulation for Investment in Limited Liability Partnership for Group Captive Power Generation
1 month ago
Disclosure under Regulation 30 of the SEBI Listing Regulation for Investment in Limited Liability Partnership for Group Captive Power Generation
1 month ago
Outcome of Board Meeting and Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for Investment in Limited Liability Partnership for Group Captive Power Generation
1 month ago
Outcome of Board Meeting and Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for Investment in Limited Liability Partnership for Group Captive Power Generation
1 month ago
Closure of Trading Window
1 month ago
Closure of Trading Window
1 month ago
Shareholders approval for Reclassification of Mr. Ravin Gandhi and Ms. Bela Gandhi from Promoter and Promoter Group category to Public Category shareholders of the Company.
2 months ago
Shareholders approval for Reclassification of Mr. Ravin Gandhi and Ms. Bela Gandhi from Promoter and Promoter Group category to Public Category shareholders of the Company.
2 months ago
Scrutinizers Report for Postal Ballot Process
2 months ago
Scrutinizers Report for Postal Ballot Process
2 months ago
Outcome proceedings and Voting Results of Postal Ballot Process for the Notice dated 30 July 2026
2 months ago
Outcome proceedings and Voting Results of Postal Ballot Process for the Notice dated 30 July 2026
2 months ago
Intimation of Upgrade in Credit Ratings by Care Ratings Limited
2 months ago
Intimation of Upgrade in Credit Ratings by Care Ratings Limited
2 months ago
Postal Ballot Notice
3 months ago
Postal Ballot Notice
3 months ago
Transcript of Earnings Conference Call held on 30 July 2026
3 months ago
Transcript of Earnings Conference Call held on 30 July 2026
3 months ago
Launch of Interactive Microsite of 39th Annual Report FY 2025-26
3 months ago
Launch of Interactive Microsite of 39th Annual Report FY 2025-26
3 months ago
Newspaper Clippings of Q1 FY27 Financial Results publication
3 months ago
Newspaper Clippings of Q1 FY27 Financial Results publication
3 months ago
Audio recording of the Earnings Conference Call held on 30 July 2026
3 months ago
Audio recording of the Earnings Conference Call held on 30 July 2026
3 months ago

Concalls & investor presentations

Nov 2026
ConcallPresentation
Jul 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
Jan 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
Jan 2022
ConcallPresentation
Oct 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Jun 2021
ConcallPresentation
Jan 2021
ConcallPresentation
Oct 2020
ConcallPresentation

Hester Biosciences Ltd Share Price Today

The Hester Biosciences Ltd share price today is ₹2120.8. During the trading session, the Hester Biosciences Ltd share price opened at ₹2162.7 and recorded an intraday high of ₹2167.9 and a low of ₹2075.5. Last closing price was ₹2175.8. Over the past 52 weeks, the Hester Biosciences Ltd share price has ranged between ₹1239.3 and ₹2683.6. The current Hester Biosciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.